The NMR LipoProfile® test, LipoScience’s first proprietary test, is an FDA-cleared blood test that directly quantifies LDL particle number (LDL-P) and provides physicians and their patients with ...

The Vantera Clinical Analyzer can identify and quantify concentrations of lipoproteins using NMR spectroscopy and proprietary signal processing algorithms. Such analysis provides physicians and ...

RALEIGH, N.C.--(BUSINESS WIRE)--LipoScience, Inc., an in vitro diagnostic company advancing patient care by developing high value proprietary clinical tests using nuclear magnetic resonance (NMR) ...

RALEIGH, N.C. – LipoScience, Inc. has entered into an agreement with ARUP Laboratories, a national clinical and anatomic pathology laboratory, to offer its proprietary NMR LipoProfile test. ARUP ...

Diagnostics company LipoScience aims to become North Carolina’s next public company. LipoScience plans to use proceeds from its stock offering to expand its sales and marketing and fund continued R&D ...

Lab testing giant LabCorp, which is based in Burlington, is acquiring Raleigh-based LipoScience in a deal worth some $85 million in cash. Shares in LipoScience, which provides testing services related ...

LipoScience, Inc., (NASDAQ: LPDX) a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care, today announced ...

Raleigh, NC, March 28, 2008 - The American Diabetes Association (ADA) and the American College of Cardiology (ACC) issued a consensus statement today that states the measurement of LDL particle number ...

LipoScience, Inc., LPDX a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and ...